Nordion, Bracco ink supply deal
Article Thumbnail ImageMarch 4, 2014 -- Canadian radioisotope firm Nordion and Bracco Imaging have signed a two-year contract to supply U.S. subsidiary Bracco Diagnostics with strontium-82.

To get access to this article and all of the content on, create a free account or sign-in now.

Member Sign In:
MemberID or E-mail Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
using your social networking account:
using your social networking

The medical isotope is produced at both Nordion's Vancouver, British Columbia, and Ottawa, Ontario, facilities.

Strontium-82 is used in Bracco's CardioGen-82 generators and decays over time into the medical isotope rubidium-82.

Rubidium-82 chloride injection is used in PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.